Correction: Corrigendum: An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray Bailey, Pierre Beaulieu, Gordon Bolger, Pierre Bonneau, Michael Bös, Dale R. Cameron, Mireille Cartier, Michael G. Cordingley, Anne-Marie Faucher, Nathalie Goudreau, Stephen H. Kawai, George Kukolj, Lisette Lagacé, Steven R. Laplante, Hans Narjes, Marc-André Poupart, Jean Rancourt, Roel E. Sentjens, Roger St George, Bruno Simoneau, Gerhard Steinmann, Diane Thibeault, Youla S. Tsantrizos, Steven M. Weldon, Chan-Loi Yong and Montse Llinàs-Brunet

Nature, 2003, vol. 426, issue 6964, 314-314

Abstract: Nature 426, 186–189 (2003). In this Letter, the ‘Competing interests statement’ should be corrected to: ‘The authors declare competing financial interests: R.E.S. was the clinical investigator and received an honorarium from Boehringer Ingelheim. All the other authors are or were employees of Boehringer Ingelheim.

Date: 2003
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature02183 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:426:y:2003:i:6964:d:10.1038_nature02183

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature02183

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().